Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01414608 · ClinicalTrials.gov registry record · Phase 3
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
A Phase 3 study, sponsored by GOG Foundation.
- Completed
- Registry status
- Phase 3
- Development phase
- 926
- Enrollment target
NCT01414608 is a Phase 3 study that has completed, run by GOG Foundation. The registered enrollment target is 926 participants.
The verdict
NCT01414608, a Phase 3 study, has completed, sponsored by GOG Foundation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 926 participants
- Enrollment target
Study Summary
This randomized phase III trial studies how well giving cisplatin and radiation therapy together with or without carboplatin and paclitaxel works in treating patients with cervical cancer has spread from where it started to nearby tissue or lymph nodes. Drugs used in chemotherapy, such as cisplatin, carboplatin, and paclitaxel, work in different ways to stop the growth of \[cancer/tumor\] cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. External radiation therapy uses high-energy x rays to kill tumor cells. Internal radiation uses radioactive material placed directly into or near a tumor to kill tumor cells. It is not yet known whether giving cisplatin and external and internal radiation therapy together with carboplatin and paclitaxel kills more tumor cells.
Interventions
- DRUG Carboplatin
- DRUG Cisplatin
- RADIATION External Beam Radiation Therapy
- RADIATION Brachytherapy
- DRUG Paclitaxel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 926 participants |
| Start Date | 2012-01-09 |
| Est. Completion | 2021-07-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01414608
The ClinicalTrials.gov registry entry for NCT01414608 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 926 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GOG Foundation, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Carboplatin is the first listed.
NCT01414608 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01414608 about?
NCT01414608 is a clinical study titled "Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer". This randomized phase III trial studies how well giving cisplatin and radiation therapy together with or without carboplatin and paclitaxel works in treating patients with cervical cancer has spread from where it started to nearby tissue or lymph nodes. Drugs used in chemotherapy, such as cisplatin,...
What is the current status of trial NCT01414608?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 926 participants. The study started on 2012-01-09. Estimated completion is 2021-07-09.
What interventions are being tested in trial NCT01414608?
The interventions under investigation include: Carboplatin (DRUG), Cisplatin (DRUG), External Beam Radiation Therapy (RADIATION), Brachytherapy (RADIATION), Paclitaxel (DRUG).
Who is sponsoring clinical trial NCT01414608?
This trial is sponsored by GOG Foundation, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.